Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
South Asian Journal of Cancer|December 7, 2019
Advances in soft-tissue sarcoma - There are no mistakes, only lessons to learn!Sameer Rastogi, Parisa Manasa, Aditi Aggarwal, et al.Mediastinum (Hong Kong, China)|February 4, 2022
Clinical approach to childhood mediastinal tumors and managementSaurav Verma, Kaushal Kalra, Sameer Rastogi, et al.Future Science OA|January 10, 2020
Long lasting response of trabectedin in patient with gastric leiomyosarcoma with liver metastasis: an update to previous reportSameer Rastogi, Kaushal Kalra, Parisa Manasa, et al.Journal of Pediatric Hematology/Oncology|May 31, 2021
Autologous Hematopoietic Stem Cell Transplant: A Potential Option for Relapsed Pediatric Acute Myeloid Leukemia With Lack of Matched Sibling Donor and Resource ChallengeKaushal Kalra, Shalabh Arora, Saurav Verma, et al.Journal of Inflammation Research|November 19, 2011
Immune response profiles after caterpillar exposure: a case reportTamar A Smith-Norowitz, Kevin B Norowitz, Stephan Kohlhoff, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 9, 2022
Health-related quality of life (HRQoL), anxiety, and depression in patients with desmoid type fibromatosisVikas Garg, Sameer Rastogi, Kaushal Kalra, et al.Journal of Sleep Disorders & Therapy|February 15, 2014
Sleep Duration, Insomnia Symptoms, and Emotion Regulation among Black WomenChristie Racine, Kaushal Kalra, Mirnova Ceide, et al.South Asian Journal of Cancer|September 27, 2021
Trabectedin in Advanced Sarcomas-Experience at a Tertiary Care Center and Review of LiteratureSaurav Verma, Kaushal Kalra, Sameer Rastogi, et al.Current Oncology (Toronto, Ont.)|August 27, 2025
Evolving Treatment Paradigms in Metastatic Hormone-Sensitive Prostate Cancer: Expert Narrative ReviewVineet Talwar, Kaushal Kalra, Akhil Kapoor, et al.Trials|February 26, 2025
A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)Adhip Arora, V Seenu, Rajinder Parshad, et al.Pageof 2